Cited by 302Diabetes and associated disordersGenetic Associations and EpidemiologyGenomics and Chromatin Dynamics

The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.

Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes

Open access

Robertson, Catherine C., Inshaw, Jamie R. J., Onengut-Gumuscu, Suna, Chen, Wei-Min, Santa Cruz, David Flores, Yang, Hanzhi, Cutler, Antony J., Crouch, Daniel J. M., Farber, Emily, Bridges, S. Louis, Edberg, Jeffrey C., Kimberly, Robert P., Buckner, Jane H., Deloukas, Panos, Divers, Jasmin, Dabelea, Dana, Lawrence, Jean M., Marcovina, Santica, Shah, Amy S., Greenbaum, Carla J., Atkinson, Mark A., Gregersen, Peter K., Oksenberg, Jorge R., Pociot, Flemming, Rewers, Marian J., Steck, Andrea K., Dunger, David B., Type 1 Diabetes Genetics Consortium, Wicker, Linda S., Concannon, Patrick, Todd, John A., Rich, Stephen S.·2021·Nature Genetics

DOI 10.1038/s41588-021-00880-5PMC PMC8273124

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

We report the largest and most diverse genetic study of type 1 diabetes (T1D) to date (61,427 participants), yielding 78 genome-wide-significant (P < 5 × 10−8) regions, including 36 that are new. We define credible sets of T1D-associated variants and show that they are enriched in immune-cell accessible chromatin, particularly CD4+ effector T cells. Using chromatin-accessibility profiling of CD4+ T cells from 115 individuals, we map chromatin-accessibility quantitative trait loci and identify five regions where T1D risk variants co-localize with chromatin-accessibility quantitative trait loci. We highlight rs72928038 in BACH2 as a candidate causal T1D variant leading to decreased enhancer accessibility and BACH2 expression in T cells. Finally, we prioritize potential drug targets by integrating genetic evidence, functional genomic maps and immune protein–protein interactions, identifying 12 genes implicated in T1D that have been targeted in clinical trials for autoimmune diseases. These findings provide an expanded genomic landscape for T1D. A large-scale genetic analysis of type 1 diabetes identifies new susceptibility variants, highlights potential regulatory mechanisms and provides genetic support for therapeutic targets for immune intervention.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41588-021-00880-5

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
<tt>edgeR</tt> : a Bioconductor package for differential expression analysis of digital gene expression data
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
Minimap2: Pairwise alignment for nucleotide sequences
Li, H. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty191 · Cited by 14,807
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,724
Second-generation PLINK: rising to the challenge of larger and richer datasets
Chang, C. C., Chow, C. C., Tellier, L. C., Vattikuti, S., Purcell, S. M., & Lee, J. J. (2015) · Gigascience · doi:10.1186/s13742-015-0047-8 · Cited by 12,709
The control of the false discovery rate in multiple testing under dependency
Benjamini, Y., & Yekutieli, D. (2001) · The Annals of Statistics · doi:10.1214/aos/1013699998 · Cited by 10,490
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Self-citation
A scaling normalization method for differential expression analysis of RNA-seq data
Robinson, M. D., & Oshlack, A. (2010) · Genome Biology · doi:10.1186/gb-2010-11-3-r25 · Cited by 7,876
The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible
Szklarczyk, D., Morris, J. H., Cook, H., Kuhn, M., Wyder, S., Simonovic, M., Santos, A., Doncheva, N. T., Roth, A., Bork, P., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw937 · Cited by 6,980

Show all 107 references

Sorted by citations

Items 101–200 of 302

HLA-focused type 1 diabetes genetic risk prediction in populations of diverse ancestry
Michalek, D. A., Tern, C., Robertson, C. C., Chen, W., Önengüt-Gümüşcü, S., & Rich, S. S. (2025) · Diabetologia · doi:10.1007/s00125-025-06563-8 · Cited by 11
Self-citation
A cross-disease, pleiotropy-driven approach for therapeutic target prioritization and evaluation
Bao, C., Tan, T., Wang, S., Gao, C., Lu, C., Yang, S., Diao, Y., Jiang, L., Jing, D., Chen, L., et al. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100757 · Cited by 11
Type 1 Diabetes Genetic Risk Scores: History, Application and Future Directions
Tosur, M., Önengüt-Gümüşcü, S., & REDONDO, M. J. (2025) · Current Diabetes Reports · doi:10.1007/s11892-025-01575-5 · Cited by 12
GWAS and autoimmunity: What have we learned and what next
Gerussi, A., Soskic, B., Asselta, R., Invernizzi, P., & Gershwin, M. E. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102922 · Cited by 10
Identification of a type 1 diabetes–associated T cell receptor repertoire signature from the human peripheral blood
Rawat, P., Shapiro, M. R., Peters, L. D., Widrich, M., Mayer-Blackwell, K., Motwani, K., Pavlović, M., al Hajj, G., Posgai, A. L., Kanduri, C., et al. (2026) · Science Advances · doi:10.1126/sciadv.adx7448 · Cited by 21
Self-citation
PiER: web-based facilities tailored for genetic target prioritisation harnessing human disease genetics, functional genomics and protein interactions
Fang, H. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac379 · Cited by 10
Association of HLA-DQ Heterodimer Residues −18β and β57 With Progression From Islet Autoimmunity to Diabetes in the Diabetes Prevention Trial–Type 1
Zhao, L. P., Skyler, J. S., Papadopoulos, G. K., Pugliese, A., Najera, J. A., Bondinas, G. P., Moustakas, A. K., Wang, R., Pyo, C., Nelson, W. C., et al. (2022) · Diabetes Care · doi:10.2337/dc21-1628 · Cited by 11
Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases
Mastracci, T. L., Apte, M. V., Amundadottir, L. T., Alvarsson, A., Artandi, S. E., Bellin, M. D., Bernal‐Mizrachi, E., Caicedo, A., Campbell‐Thompson, M., Cruz‐Monserrate, Z., et al. (2022) · Pancreas · doi:10.1097/mpa.0000000000002170 · Cited by 10
Identification of a type 1 diabetes-associated T cell receptor repertoire signature from the human peripheral bloodPreprint
Rawat, P., Shapiro, M. R., Peters, L. D., Widrich, M., Mayer-Blackwell, K., Motwani, K., Pavlović, M., Hajj, G. S. A., Posgai, A. L., Kanduri, C., et al. (2024) · medRxiv · doi:10.1101/2024.12.10.24318751 · Cited by 10
Self-citation
Untangling the genetics of beta cell dysfunction and death in type 1 diabetes
Robertson, C. C., Elgamal, R. M., Henry-Kanarek, B. A., Arvan, P., Chen, S., Dhawan, S., Eizirik, D. L., Kaddis, J. S., Vahedi, G., Parker, S. C. J., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101973 · Cited by 12
Self-citation
Genetic relations between type 1 diabetes, coronary artery disease and leukocyte counts
Adebekun, J., Nadig, A., Saarah, P., Asgari, S., Kachuri, L., & Alagpulinsa, D. A. (2024) · Diabetologia · doi:10.1007/s00125-024-06247-9 · Cited by 9
The type 1 diabetes candidate genes PTPN2 and BACH2 regulate the IFN-α-induced crosstalk between JAK/STAT and MAPKs pathways in human beta cells
Roca-Rivada, A., Oliveira, J. G., Martín-Vázquez, E., de Brachène, A. C., Yi, X., Costa-Júnior, J. M., Zimath, P. L., Goethem, F. V., Pattou, F. N., Kerr-Conte, J., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105932 · Cited by 9
Identification of novel type 1 and type 2 diabetes genes by co-localization of human islet eQTL and GWAS variants with colocRedRibbon
Piron, A., Szymczak, F., Folon, L., Crouch, D. J. M., Papadopoulou, T., Lytrivi, M., Yue, T., Alvelos, M. I., Colli, M. L., Yi, X., et al. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.101004 · Cited by 11
Self-citation
Host control of persistent Epstein–Barr virus infection
Schmidt, A., Alawathurage, T. M., David, F. S., Ogawa, Y., Frach, L., Richter, S., Schaefer, M., Mathey, C. M., Henne, S. K., Japan COVID-19 Task Force, et al. (2026) · Nature · doi:10.1038/s41586-026-10274-4 · Cited by 9
Clinical and experimental treatment of type 1 diabetes
Long, S. A., & Buckner, J. H. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac077 · Cited by 9
Self-citation
Genetic variation at 11q23.1 confers colorectal cancer risk by dysregulation of colonic tuft cell transcriptional activator POU2AF2
Rajasekaran, V., Harris, B. T., Osborn, R. T., Smillie, C. L., Donnelly, K., Bacou, M., Esiri-Bloom, E., Ooi, L. Y., Allan, M., Walker, M., et al. (2024) · Gut · doi:10.1136/gutjnl-2024-332121 · Cited by 9
Sex as a modifier of genetic risk for type 1 diabetes
Qu, H., & Hakonarson, H. H. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70124 · Cited by 8
The Application of High‐Throughput Approaches in Identifying Novel Therapeutic Targets and Agents to Treat Diabetes
He, S., & Lim, G. E. (2022) · Advanced Biology · doi:10.1002/adbi.202200151 · Cited by 7
Leveraging type 1 diabetes human genetic and genomic data in the T1D knowledge portal
Kudtarkar, P., Costanzo, M. C., Sun, Y., Jang, D., Koesterer, R., Mychaleckyj, J. C., Nayak, U., Önengüt-Gümüşcü, S., Rich, S. S., Flannick, J. A., et al. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002233 · Cited by 7
Self-citation
Th2 cell clonal expansion at diagnosis in human type 1 diabetes
Narsale, A. A., Almanza, F., Tran, T., Lam, B., Seo, D., Vu, A., Long, S. A., Cooney, L., Serti, E., & Davies, J. D. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109829 · Cited by 8
Genetic regulation of RNA splicing in human pancreatic isletsPreprint
Atla, G., Bonàs‐Guarch, S., Beucher, A., Cuenca-Ardura, M., García-Hurtado, J., Morán, I., Irimia, M., Prasad, R. B., Gloyn, A. L., Marselli, L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.11.468254 · Cited by 8
Population-scale multiome immune cell atlas reveals complex disease driversPreprint
Kanai, M., Delorey, T. M., Honkanen, J. K., Rodosthenous, R. S., Juvila, J., Murphy, S. M., Teixeira-Soldano, I., Hwang, H. S., Karjalainen, J. M., Halonen, J., et al. (2025) · medRxiv · doi:10.1101/2025.11.25.25340489 · Cited by 8
Immunometabolic biomarkers for partial remission in type 1 diabetes mellitus
Gómez-Muñoz, L., Domínguez‐Bendala, J., Pastori, R. L., & Vives‐Pi, M. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.10.005 · Cited by 7
Is the NOD mouse a good model for type 1 diabetes?
Wong, F. S., Pearson, J. A., & Li, W. (2025) · Diabetologia · doi:10.1007/s00125-025-06579-0 · Cited by 8
Association of the rs1990760, rs3747517, and rs10930046 polymorphisms in the IFIH1 gene with susceptibility to autoimmune diseases: a meta-analysis
Xiao, Z., Luo, S., Zhou, Y., Pang, H., Yin, W., Qin, J., Xie, Z., & Zhou, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1051247 · Cited by 7
DNA methylation differences within INS, PTPN22 and IL2RA promoters in lymphocyte subsets in children with type 1 diabetes and controls
Pahkuri, S., Ekman, I., Vandamme, C., Näntö-Salonen, K., Toppari, J., Veijola, R., Knip, M., Kinnunen, T., Ilonen, J., & Lempainen, J. (2023) · Autoimmunity · doi:10.1080/08916934.2023.2259118 · Cited by 5
Genetic evidence for efficacy of targeting IL-2, IL-6 and TYK2 signalling in the prevention of type 1 diabetes: a Mendelian randomisation study
Heikkilä, T. E., Kaiser, E., Lin, J., Gill, D., Koskenniemi, J. J., & Karhunen, V. (2024) · Diabetologia · doi:10.1007/s00125-024-06267-5 · Cited by 7
Roles of TULA-family proteins in T cells and autoimmune diseases
Wang, H., CONCANNON, P. J., & Ge, Y. (2024) · Genes and Immunity · doi:10.1038/s41435-024-00300-8 · Cited by 7
Self-citation
Bayesian Effect Size Ranking to Prioritise Genetic Risk Variants in Common Diseases for Follow‐Up Studies
Crouch, D. J. M., Inshaw, J., Robertson, C. C., Ng, E. S., Zhang, J.-Y., Chen, W.-M., Onengut-Gumuscu, S., Cutler, A. J., Sidore, C., Cucca, F., et al. (2025) · Genetic Epidemiology · doi:10.1002/gepi.22608 · Cited by 4
Self-citation
Thymocyte regulatory variant alters transcription factor binding and protects from type 1 diabetes in infants
Sandholm, N., García, A. R., Pękalski, M. Ł., Inshaw, J. R. J., Cutler, A. J., & Todd, J. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-18296-4 · Cited by 7
Self-citation
Shared and distinct genetics of pure type 1 diabetes and type 1 diabetes with celiac disease, homology in their auto-antigens and immune dysregulation states: a study from North India
Kaur, N., Singh, J., Minz, R. W., Anand, S., Saikia, B., Bhadada, S. K., Dayal, D., Kumar, M., & Dhanda, S. K. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02258-5 · Cited by 7
Multi-ancestry Genome-Wide Association Meta-Analysis Identifies Novel Loci in Atopic DermatitisPreprint
Oliva, M., Sarkar, M. K., March, M., Saeidian, A. H., Mentch, F. D., Hsieh, C.-L., Tang, F., Uppala, R., Patrick, M. T., Li, Q., et al. (2024) · medRxiv · doi:10.1101/2024.06.17.24308897 · Cited by 7
Circulating hsa-miR-320a and its regulatory network in type 1 diabetes mellitus
Nizam, R., Malik, M. Z., Jacob, S. P., Alsmadi, O. A., Koistinen, H. A., Tuomilehto, J. O., Alkandari, H., Al‐Mulla, F., & Thanaraj, T. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1376416 · Cited by 6
Adult-onset type 1 diabetes: early detection, differential diagnosis, and emerging disease-modifying therapies
Wagner, R. J., Füchtenbusch, M., Hummel, M., Miszon, M., Pfützner, A., Tan, S., & Wiesner, T. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.113047 · Cited by 7
The long and winding road: From mouse linkage studies to a novel human therapeutic pathway in type 1 diabetes
Rojas, M., Heuer, L. S., Zhang, W., Chen, Y., & Ridgway, W. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.918837 · Cited by 6
Dynamic chromatin architecture identifies new autoimmune-associated enhancers for IL2 and novel genes regulating CD4+ T cell activation
Pahl, M. C., Sharma, P. K., Thomas, R. M., Thompson, Z., Mount, Z., Pippin, J. A., Morawski, P. A., Sun, P., Su, C., Campbell, D., et al. (2024) · eLife · doi:10.7554/elife.96852 · Cited by 6
Integrative Proteogenomic Analyses Provide Novel Interpretations of Type 1 Diabetes Risk Loci Through Circulating Proteins
Lu, T., Manousaki, D., Sun, L., & Paterson, A. D. (2025) · Diabetes · doi:10.2337/db24-0380 · Cited by 7
Predicting diabetes risk in diverse populations: what next?
Mercader, J., Ng, M., Manning, A. K., & Rich, S. (2021) · The Lancet Diabetes and Endocrinology · doi:10.1016/s2213-8587(21)00287-4 · Cited by 5
Self-citation
Implementation of Precision Genetic Approaches for Type 1 and 2 Diabetes
Ronald, C. W., & Chan, J. C. N. (2022) · Springer eBooks · doi:10.1007/978-3-030-98927-9_5 · Cited by 6
Association analysis between the TLR9 gene polymorphism rs352140 and type 1 diabetes
Wang, Y., Xia, Y., Chen, Y., Xu, L., Sun, X., Li, J., Huang, G., Li, X., Xie, Z., & Zhou, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1030736 · Cited by 7
Linkage analysis using whole exome sequencing data implicates SLC17A1, SLC17A3, TATDN2 and TMEM131L in type 1 diabetes in Kuwaiti families
Hebbar, P., Nizam, R., John, S. E., Antony, D., Dashti, M., Channanath, A. M., Shaltout, A., Alkhandari, H., Koistinen, H. A., Tuomilehto, J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-42255-2 · Cited by 7
Evaluation of polygenic scoring methods in five biobanks reveals greater variability between biobanks than between methods and highlights benefits of ensemble learningPreprint
Monti, R., Eick, L., Hudjashov, G., Läll, K., Kanoni, S., Wolford, B. N., Wingfield, B., Pain, O., Wharrie, S., Jermy, B. S., et al. (2023) · medRxiv · doi:10.1101/2023.11.20.23298215 · Cited by 6
Effects of parental autoimmune diseases on type 1 diabetes in offspring can be partially explained by HLA and non-HLA polymorphisms
Wang, F., Liu, A., Yang, Z., Vartiainen, P., Jukarainen, S., Koskela, S., Oram, R. A., Allen, L. A., Ritari, J., Partanen, J., et al. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100854 · Cited by 5
Modulating immune response for the prevention and treatment of type 1 diabetes
Vohidova, D., Desai, P., Lozano, A. M., & Omid Veiseh, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1715863 · Cited by 5
What is the role of puberty in the development of islet autoimmunity and progression to type 1 diabetes?
Peltonen, E. J., Veijola, R., Ilonen, J., Knip, M., Niinikoski, H., Toppari, J., Virtanen, H. E., Virtanen, S. M., Peltonen, J., & Nevalainen, J. (2023) · European Journal of Epidemiology · doi:10.1007/s10654-023-01002-7 · Cited by 5
Priority index for asthma (PIA): In silico discovery of shared and distinct drug targets for adult- and childhood-onset disease
Bao, C., Gu, L., Wang, S., Zou, K., Zhang, Z., Jiang, L., Chen, L., & Fang, H. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107095 · Cited by 5
Shifts in isoform usage underlie transcriptional differences in regulatory T cells in type 1 diabetes
Newman, J. R. B., Long, S. A., Speake, C., Greenbaum, C. J., Cerosaletti, K. M., Rich, S. S., Önengüt-Gümüşcü, S., McIntyre, L. M., Buckner, J. H., & CONCANNON, P. J. (2023) · Communications Biology · doi:10.1038/s42003-023-05327-7 · Cited by 4
Self-citation
Priority index for critical Covid-19 identifies clinically actionable targets and drugs
Zhang, Z., Wang, S., Jiang, L., Wei, J., Lu, C., Li, S., Diao, Y., Fang, Z., He, S., Tan, T., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-05897-0 · Cited by 5
Identification of TACSTD2 as novel therapeutic targets for cisplatin-induced acute kidney injury by multi-omics data integration
Deng, Z., Dong, Z., Wang, Y., Dai, Y., Liu, J., & Deng, F. (2024) · Human Genetics · doi:10.1007/s00439-024-02641-w · Cited by 5
Enhanced fracture risk prediction: a novel multi-trait genetic approach integrating polygenic scores of fracture-related traits
Xiao, X., & Wu, Q. F. (2024) · Osteoporosis International · doi:10.1007/s00198-024-07105-5 · Cited by 5
Longitudinal changes in DNA methylation during the onset of islet autoimmunity differentiate between reversion versus progression of islet autoimmunity
Carry, P. M., Vanderlinden, L. A., Johnson, R. K., Buckner, T., Steck, A. K., Kechris, K. J., Yang, I. V., Fingerlin, T. E., Fiehn, O., Rewers, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1345494 · Cited by 5
Self-citation
Genetics of C-Peptide and Age at Diagnosis in Type 1 Diabetes
Roshandel, D., Spiliopoulou, A., McGurnaghan, S. J., Iakovliev, A., Lipschutz, D., Hayward, C., Bull, S. B., Klein, B. E. K., Lee, K. E., Kinney, G. L., et al. (2024) · Diabetes · doi:10.2337/db24-0340 · Cited by 6
Self-citation
Linking epigenetic mechanisms of T cell dysfunction with pathophysiology of type 1 diabetes mellitus
Jabri, A., Elsalti, A., Alsharif, M., Alsharif, R., Abbad, T., Sibai, D., Taftafa, B., Mhannayeh, A., Khan, M. I., & Yaqinuddin, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1664255 · Cited by 5
Optimizing Type 1 Diabetes Screening in People With Family History: A German Perspective
Danne, T., Kapellen, T. M., Widholz, S. A., Wabitsch, M., & Ziegler, R. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251383911 · Cited by 4
The perfect storm: unraveling the interplay of genetic predisposition and viral triggers in type 1 diabetes pathogenesis
Veronese-Paniagua, D., & Millman, J. R. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1734431 · Cited by 5
Single-cell RNA-seq analysis of longitudinal CD4+ T cell samples reveals cell-type-specific changes during early stages of type 1 diabetes
Biradar, R., Ullah, U., Lönnberg, T., Junttila, S., Tomi, S., Norman, S. Z., Starskaia, I., Paulin, N., Mikkola, L., Vaarala, O., et al. (2025) · Genome Medicine · doi:10.1186/s13073-025-01574-x · Cited by 5
“Two-birds-one-stone” oral colon-targeted nanomedicine for ulcerative colitis precise therapy via remodeling inflammation microenvironment and inhibiting lipid peroxidation/ferroptosis
Liu, R., Yan, J., Wang, Z., Liu, H., Ma, X., Wang, Y., Sun, X., Zhang, B., Zhao, W., Zhang, J., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.159736 · Cited by 4
Hyperglycemia impairs EAAT2 glutamate transporter trafficking and glutamate clearance in islets of Langerhans: implications for type 2 diabetes pathogenesis and treatment
Galli, A., Moretti, S., Dule, N., Cairano, E. S. D., Castagna, M., Marciani, P., Battaglia, C., Bertuzzi, F., Fiorina, P., Pastore, I., et al. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00069.2024 · Cited by 5
Modulation of autoimmune diabetes by N-ethyl-N-nitrosourea- induced mutations in non-obese diabetic mice
Chatenoud, L., Marquet, C., Valette, F., Scott, L., Quan, J., Bu, C. H., Hildebrand, S., Moresco, E. M. Y., Bach, J., & Beutler, B. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049484 · Cited by 4
Rs864745 in JAZF1, an Islet Function Associated Variant, Correlates With Plasma Lipid Levels in Both Type 1 and Type 2 Diabetes Status, but Not Healthy Subjects
Dai, H., Yu, Q., Lv, H. X., Jiang, L., Jiang, H., Shen, M., Chen, H., Chen, Y., Zheng, S., Fu, Q., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.898893 · Cited by 4
Use of a glycomics array to establish the anti-carbohydrate antibody repertoire in type 1 diabetes
Tran, P. M. H., Dong, F., Kim, E., Richardson, K. P., Tran, L. K. H., Waugh, K., Hopkins, D., Cummings, R. D., Wang, P. G., Rewers, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34341-2 · Cited by 4
Self-citation
A Type 1 Diabetes Polygenic Score Is Not Associated With Prevalent Type 2 Diabetes in Large Population Studies
Srinivasan, S., Wu, P., Mercader, J. M., Udler, M. S., Porneala, B., Bartz, T. M., Floyd, J. S., Sitlani, C. M., Guo, X., Haessler, J., et al. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad123 · Cited by 4
Self-citation
Genotypes predisposing for celiac disease and autoimmune diabetes and risk of infections in early childhood
Størdal, K., Tapia, G., Lund‐Blix, N. A., & Stene, L. C. (2023) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.12078 · Cited by 4
Gene association analysis to determine the causal relationship between immune-mediated inflammatory diseases and frozen shoulder
Zhou, Y., Yin, X., Wang, C., & Yu, D. (2024) · Medicine · doi:10.1097/md.0000000000038055 · Cited by 4
Genetics of type-1 diabetes
Ikegami, H., & Noso, S. (2024) · Diabetology International · doi:10.1007/s13340-024-00754-1 · Cited by 4
Disease-associated variants are enriched for altering cell-type-specific gene co-expression relationshipsPreprint
Kaptijn, D., Losert, C., Korshevniuk, M., Oelen, R., Vochteloo, M., Deelen, P., Warmerdam, R., Kooijmans, A., Considine, D., Tsepilov, Y. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.06.674678 · Cited by 4
Mapping Inherited Genetic Variation with Opposite Effects on Autoimmune Disease and Four Cancer Types Identifies Candidate Drug Targets Associated with the Anti-Tumor Immune Response
Chen, J., Epstein, M. P., Schildkraut, J. M., & Kar, S. (2025) · Genes · doi:10.3390/genes16050575 · Cited by 4
Genetic and transcriptional dysregulation of innate antiviral immune pathways in type 1 diabetes
Mønsted, M. Ø., Pedersen, K., Jensen, M. H., Kaur, S., Sustacha, S. C., Holm, L. J., Buschard, K., Pociot, F., & Haupt‐Jorgensen, M. (2025) · Immunology Letters · doi:10.1016/j.imlet.2025.107060 · Cited by 3
Self-citation
Early glucose metabolism in children at risk for type 1 diabetes based on islet autoantibodies compared to low-risk control groups
Helminen, O., Pokka, T. M.-L., Aspholm, S., Ilonen, J., Simell, O., Knip, M., & Veijola, R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.972714 · Cited by 3
Epidemiology and Pathogenesis of Type 1 Diabetes
Stene, L. C., & Lernmark, Å. (2023) · Springer eBooks · doi:10.1007/978-3-031-20999-4_2 · Cited by 3
MDA5 variants trade antiviral activity for protection from autoimmune disease
Wallace, C., Singh, R., & Modis, Y. (2025) · BMC Medical Genomics · doi:10.1186/s12920-025-02171-y · Cited by 4
Sex specific genomic insights into type 1 diabetes through GWAS and single cell transcriptome analysis
Qu, H., Ostberg, K., Slater, D. J., Wang, F., Snyder, J., Hou, C., Connolly, J. J., March, M., Glessner, J., Kao, C., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113181 · Cited by 3
Affected brother as the highest risk factor of type 1 diabetes development in children and adolescents: One center data before implementing type 1 diabetes national screening
Wędrychowicz, A., Grzelak, T., Alicja, P., Maria, S. D. D. A., Mari, M., & Starzyk, J. (2023) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/172446 · Cited by 3
Role of the Neanderthal Genome in Genetic Susceptibility to COVID-19: 3p21.31 Locus in the Spotlight
Yaghmouri, M., & Izadi, P. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10669-w · Cited by 3
Does HLA explain the high incidence of childhood-onset type 1 diabetes in the Canary Islands? The role of Asp57 DQB1 molecules
Nóvoa-Medina, Y., Marcelino-Rodriguez, I., Suárez, N. M., Barreiro-Bautista, M., Rivas-García, E., Sánchez-Alonso, S., González-Martínez, G., Quinteiro-González, S., Domínguez, Á., Cabrera, M., et al. (2024) · BMC Pediatrics · doi:10.1186/s12887-024-04983-w · Cited by 4
Exploring antigenic variation in autoimmune endocrinopathy
Mavridou, M., & Pearce, S. H. S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1561455 · Cited by 3
Reduced Function of the Adaptor SH2B3 Promotes T1D via Altered Cytokine-Regulated, T-Cell–Intrinsic Immune Tolerance
Watson, T. K., Rosen, A. B. I., Drow, T., Medjo, J. A., MacQuivey, M. A., Ge, Y., Liggitt, D., Grosvenor, D. A., Dill‐McFarland, K. A., Altman, M. C., et al. (2025) · Diabetes · doi:10.2337/db24-0655 · Cited by 3
Self-citation
Gluten‐Free Diet Induces Small‐Scale Changes Across Multiple T‐Cell Subsets in NOD Mice
Niederlová, V., Michalik, J., Drabonova, B., Císařová, R., Funda, D. P., & Štěpánek, O. (2025) · European Journal of Immunology · doi:10.1002/eji.202451559 · Cited by 4
Identification of functional enhancer variants associated with type I diabetes in CD4+ T cells
Mishra, A., Jajodia, A., Weston, E., Jayavelu, N. D., García, M. G., Hossack, D., & Hawkins, R. D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1387253 · Cited by 2
Design and interpretation of eQTL-GWAS colocalisation studies: Lessons from a large-scale evaluation
Reales, G., Pullin, J. M., Manipur, I., Vigorito, E., & Wallace, C. (2026) · PLoS Genetics · doi:10.1371/journal.pgen.1012141 · Cited by 2
Immune cell-based transcriptomic Mendelian randomization and colocalization study on type 1 diabetes
Sklar, J., Stacey, D., Nickel, G., Butterworth, A. S., Allara, E., & Gaziano, L. (2025) · BMC Medicine · doi:10.1186/s12916-025-04527-8 · Cited by 4
Exome Sequencing of a Type 1 Diabetes Mellitus Family Exposes Both Common and Individualized Rare Variants Contributing to Pathogenesis
Ibrahim, T. A. M., Ali, R. S., Abdullah, M. A., & Ibrahim, M. E. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/3346256 · Cited by 2
Genetic pleiotropy underlying obesity and autoimmune disorders: a large-scale cross-trait gwas analysis in European ancestry populations
Jiang, X., Li, S., Zhang, S., Li, J., Liu, D., & Zhao, H. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07422-1 · Cited by 2
Association of prenatal glycemic marker cumulative exposure with placental DNA methylation change
Habtewold, T. D., Biedrzycki, R. J., Wijesiriwardhana, P., Asefa, N. G., & Ayele, F. T. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag006 · Cited by 2
Motif-Based Hypergraph Representation Learning: Transductive and Inductive Inference for Gene Regulatory Networks
Wu, S., Tang, M., Zi, T., Liu, L., Qiao, S., Ding, G., & Gao, W. D. (2026) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2026.3685617 · Cited by 2
Population-scale immune multiome atlas reveals regulatory disease mechanisms
Kanai, M., Delorey, T. M., Jarno, H., Rodosthenous, R. S., Juvila, J., Murphy, S., Teixeira-Soldano, I., Hwang, H. S., Karjalainen, J. M., Halonen, J., et al. (2026) · Nature · doi:10.1038/s41586-026-11078-2 · Cited by 16
fcfdr: an R package to leverage continuous and binary functional genomic data in GWAS
Hutchinson, A., Liley, J., & Wallace, C. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04838-0 · Cited by 2
Polygenic risk associated with Alzheimer’s disease and other traits influences genes involved in T cell signaling and activation
Dressman, D., Tasaki, S., Yu, L., Schneider, J. A., Bennett, D. A. A., Elyaman, W., & Vardarajan, B. N. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1337831 · Cited by 3
Shared Genes and Pathways in Ulcerative Colitis and Ankylosing Spondylitis: Functional Validation and Implications for Diagnosis
Li, L., An, G., Li, F., Zhang, D., Zhu, X., Liang, C., Zhao, Y. X., Xie, K., Zhou, P., Zhu, H., et al. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s497201 · Cited by 2
Exploring the functional, protective, and transcriptomic effects of GIP on cytokine-exposed human pancreatic islets and EndoC-βH5 cells
Henriksen, K., Jørgensen, A., Kaur, S., Gerwig, R. H., Svane, C. A. B., Knop, F. K., & Størling, J. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112522 · Cited by 2
Protocol for the development of a core outcome set for type 1 diabetes risk screening
Chen, C., Luca, S., Hansen, A., Wherrett, D. K., Witteman, H. O., Chakraborty, P. K., L’Espérance, A., Wilson, M. G., McGavock, J., Delorme, S., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-099537 · Cited by 2
Genome-Wide Aggregated Trans Effects Analysis for Circulating Proteins Indicates a Key Role of Immune Checkpoints in Type 1 Diabetes
Zhou, X., Iakovliev, A., McGurnaghan, S. J., Erabadda, B., Hayward, C., McKeigue, P., Spiliopoulou, A., & Colhoun, H. M. (2025) · Diabetes · doi:10.2337/db25-0067 · Cited by 2
TLR5 influences the development of type 1 diabetes
Buschard, K., Krogvold, L., Pociot, F., Gerling, I., Thea, R., Dahl‐Jørgensen, K., & Hansen, C. H. F. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005111 · Cited by 3
Self-citation
Silencer variants are key drivers of gene up-regulation in Alzheimer’s disease
Huang, D., & Ovcharenko, I. (2026) · Science Advances · doi:10.1126/sciadv.adz3323 · Cited by 3
Genetic Variants Associated with Neuropeptide Y Autoantibody Levels in Newly Diagnosed Individuals with Type 1 Diabetes
Mansachs, S. J., Villumsen, S. O., Johannesen, J., Lind, A., Kaur, S., & Pociot, F. (2022) · Genes · doi:10.3390/genes13050869 · Cited by 4
Self-citation
Structural plasticity in I-Ag7 links autoreactivity to hybrid insulin peptides in type I diabetes
Erausquin, E., Serra, P., Parras, D., Santamaría, P., & López‐Sagaseta, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.924311 · Cited by 2
From genome to phenome via the proteome: broad capture, antibody-based proteomics to explore disease mechanismsPreprint
Koprulu, M., Carrasco-Zanini, J., Wheeler, E., Lockhart, S. M., Kerrison, N. D., Wareham, N. J., Pietzner, M., & Langenberg, C. (2022) · medRxiv · doi:10.1101/2022.08.19.22278984 · Cited by 2
Comparative Multi-omic Mapping of Human Pancreatic Islet Endoplasmic Reticulum and Cytokine Stress Responses Provides Insights into Type 2 Diabetes GeneticsPreprint
Sokolowski, E. K., Kursawe, R., Selvam, V., Bhuiyan, R. M., Thibodeau, A., Zhao, C. G., Spracklen, C. N., Ucar, D., & Stitzel, M. L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.17.580646 · Cited by 2
Aberrant TNF signaling in pancreatic lymph nodes of patients with Type 1 DiabetesPreprint
Abedi, M., Rai, P., Zhou, Y., Liu, C., Johnson, I., Chandra, A., Fasolino, M., Rostami, S. Y., Kaestner, K. H., Naji, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.31.596885 · Cited by 2
Rebalancing the Immune System to Treat Type 1 DiabetesPreprint
Müller, Y. D., Ho, P., Bluestone, J. A., & Tang, Q. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041599 · Cited by 5

Authors: Robertson, C. C., Inshaw, J. R. J., Onengut-Gumuscu, S., Chen, W.-M., Santa Cruz, D. F., Yang, H., Cutler, A. J., Crouch, D. J. M., Farber, E., Bridges, S. L., Edberg, J. C., Kimberly, R. P., Buckner, J. H., Deloukas, P., Divers, J., Dabelea, D., Lawrence, J. M., Marcovina, S., Shah, A. S., Greenbaum, C. J., Atkinson, M. A., Gregersen, P. K., Oksenberg, J. R., Pociot, F., Rewers, M. J., Steck, A. K., Dunger, D. B., Type 1 Diabetes Genetics Consortium, Wicker, L. S., Concannon, P., Todd, J. A., & Rich, S. S.
Affiliations: University of Virginia (US)
Centre for Human Genetics (GB)
Hospital for Special Surgery (US)
University of Alabama at Birmingham (US)
Benaroya Research Institute (US)
Queen Mary University of London (GB)
NYU Grossman Long Island School of Medicine (US)
Colorado School of Public Health (US)
Kaiser Permanente (US)
Medpace (United States) (US)
Cincinnati Children's Hospital Medical Center (US)
University of Florida (US)
Northwell Health (US)
University of California, San Francisco (US)
University of Copenhagen (DK)
University of Colorado Anschutz (US)
University of Cambridge (GB)
Corresponding author: Todd, John A.
ORCID: Robertson, Catherine C.
Inshaw, Jamie R. J.
Onengut-Gumuscu, Suna
Chen, Wei-Min
Yang, Hanzhi
Cutler, Antony J.
Crouch, Daniel J. M.
Farber, Emily
Bridges, S. Louis
Kimberly, Robert P.
Buckner, Jane H.
Deloukas, Panos
Divers, Jasmin
Dabelea, Dana
Lawrence, Jean M.
Marcovina, Santica
Shah, Amy S.
Greenbaum, Carla J.
Atkinson, Mark A.
Gregersen, Peter K.
Oksenberg, Jorge R.
Pociot, Flemming
Rewers, Marian J.
Steck, Andrea K.
Dunger, David B.
Wicker, Linda S.
Concannon, Patrick
Todd, John A.
Rich, Stephen S.
Venue: Nature Genetics
Publisher: Springer Science and Business Media LLC
Published: 2021-06-14
Volume: 53
Issue: 7
Pages: 962-971
ISSN: 1061-4036 (ISSN-L)
1546-1718
DOI: 10.1038/s41588-021-00880-5
PMC: PMC8273124
OpenAlex: W3171115266
Semantic Scholar: e41e3ba0695f1da1b7c897ccfd64b223b9963243
Cited by: 302
References: 107
Citations by year: 2026: 42 · 2025: 63 · 2024: 66 · 2023: 65 · 2022: 39 · 2021: 26
FWCI: 27.56
Type: journal article
Language: en
Open access: green
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Genetics (publishedVersion)
bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders: Juvenile Diabetes Research Foundation (4-SRA-2017-473-A-A)
Wellcome Trust (107212/A/15/Z)
U.S. Department of Health & Human Services | NIH | U.S. National Library of Medicine (5T32LM012416)
University of Virginia
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (N01-AR-0-2247, N01 AR-6-2278)
U.S. Department of Health & Human Services | National Institutes of Health (UL1-TR001417)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (U48/CCU919219, U01 DP000250, 107212/A/15/Z, U01 DP000247, U18DP000247-06A1, U01 DP000246, U58/CCU019235-4, U01 DP000244, U18DP002710-01, U48/CCU519239, U01 DP000248, 1U18DP002709, U01 DK103282, U01 DK127404, R01 DK032493, P30 DK116073, DK-115694, DP3-111906, U01 DK-062418)
U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (200-2010-35171)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (P01AI042288)
National Multiple Sclerosis Society (SI-2001-35701)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1 TR000154)
JDRF
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords: type 1 diabetes, genetic risk variants, fine mapping, chromatin accessibility, CD4+ T cells, BACH2, enhancer accessibility, causal variants, therapeutic target, immune cells
MeSH terms: Alleles, Chromosome Mapping, Diabetes Mellitus, Type 1, Humans, Genetic Variation, CD4-Positive T-Lymphocytes, Autoimmunity, Gene Expression, Genetic Predisposition to Disease, Genomics, Protein Interaction Mapping, Drug Discovery, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks